Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PIK3CD antisense RNA 1 (PIK3CD-AS1) is a long non-coding RNA (lncRNA) located antisense to the PIK3CD gene. It does not encode a protein but is involved in the regulation of PIK3CD gene expression, likely through mechanisms involving transcriptional interference or chromatin modification. PIK3CD-AS1 shows tissue- and development-specific expression, particularly in the brain, and its expression is increased in cell models and tissues from patients with schizophrenia, suggesting a role in neurodevelopment and psychiatric disease[1][2][4]. Current research focuses on its potential regulatory function on PIK3CD and related pathways, but its direct molecular mechanisms, therapeutic potential, and biomarker value remain uncharacterized. There is no reported interaction with drugs, nor is there evidence it functions as a classical therapeutic target such as a receptor, enzyme, or transporter[1][2][5]. Key evidence suggests that PIK3CD-AS1 is not a conventional drug target but rather a regulatory lncRNA with possible roles in disease association and gene expression regulation[1][2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PIK3CD antisense RNA 1 (PIK3CD-AS1).